Nanotechnology Project

Topics

Policy

  • publications/archive August 25, 2009 Nanotechnology and Consumer Products
  • news/archive July 29, 2009 5 years on - a beacon or just a landmark? A new report from The Responsible Nano Forum marks the 5 year anniversary of the release of the seminal report from the Royal Society and Royal Academy of Engineering Nanoscience and Nanotechnologies: opportunities and uncertainties.
  • publications/archive April 28, 2009 PEN 18 - Oversight of Next Generation Nanotechnology Existing health and safety agencies are unable to cope with the risk assessment, standard setting and oversight challenges of advancing nanotechnology.
  • events/archive April 28, 2009 Oversight of Next Generation Nanotechnology When the Environmental Protection Agency (EPA) was founded, automobiles ran on leaded gasoline without catalytic converters. A landmark report by J. Clarence Davies, Oversight of Next Generation Nanotechnology, describes how existing health and safety agencies are unable to cope with the risk assessment, standard setting and oversight challenges of 21st century technology. video
  • news/archive April 28, 2009 Former EPA Official Calls For New Environmental & Consumer Protection Agency Existing health and safety agencies are unable to cope with the risk assessment, standard setting and oversight challenges of advancing nanotechnology. In a landmark report, Oversight of Next Generation Nanotechnology, J. Clarence Davies highlights the need for a new agency to address current forms of pollution and to deal with the health and environmental impacts of the technically complex products promised by rapid 21st century scientific advances. video
  • events/archive March 25, 2009 Synthetic Biology: The Next Biotech Revolution Is Brewing Early applications of synthetic biology may be adequately addressed by the existing regulatory framework for biotechnology, but further advances in this emerging field are likely to create much greater challenges for the U.S. government, according to a new report authored by Michael Rodemeyer of the University of Virginia. video
  • news/archive February 26, 2009 Revisiting the Toxic Substances Control Act of 1976 Today the U.S. House of Representatives began the process of re-examining the Toxic Substances Control Act of 1976. According to the the Subcommittee on Commerce, Trade, and Consumer Protection, “The hearing will address critical gaps in the statute and explore how these gaps hinder effective chemical safety policy in the United States.” video
  • news/archive February 11, 2009 Stimulus Debate Highlights Need for Focus on Nanotech Risks The nearly $800 billion stimulus package being debated in Congress contains a number of measures intended to improve information technology, infrastructure and the energy economy in the United States – all areas that will be greatly aided by nanotechnology. Today, the House of Representatives passed legislation that makes the importance of understanding the possible risks posed by engineered nanomaterials a centerpiece of the goverment’s reauthorization of funding for nanotechnology research. The bill highlights the growing need to learn more about the possible environmental, health and safety dangers posed by some nanoscale materials.
  • news/archive January 28, 2009 World’s First Mandatory National Nanotech Requirement Pending Canada is reportedly planning in February to become the first nation in the world to require companies to detail their use of engineered nanomaterials. The information gathered under the requirement will be used to evaluate the risks of engineered nanomaterials and will help to develop appropriate safety measures to protect human health and the environment.
  • publications/archive January 27, 2009 PEN 16 - Nanotechnology: The Social and Ethical Issues “It is crucial to address social and ethical issues now as we consider both the substantial potential risks of nanotechnology and its possible significant contributions to our well-being and environmental sustainability,” says report author Ronald Sandler. PEN 16 emphasizes ways in which these issues intersect with governmental functions and responsibilities, including science and technology policy, as well as research funding, regulation and work on public engagement.
  • news/archive January 27, 2009 Ethical Evaluations of Nanotechnology Recent action in Congress to reauthorize the U.S. federal nanotechnology research program offers the chance to address the social and ethical issues concerning the emerging scientific field, experts say. “It is crucial to address social and ethical issues now as we consider both the substantial potential risks of nanotechnology and its possible significant contributions to our well-being and environmental sustainability,” says Ronald Sandler, Northeastern University philosophy professor and author of a new report released today by the Project.
  • publications/archive January 14, 2009 PEN 17 - A Hard Pill to Swallow Historically, the regulation of dietary supplements has been a significant challenge for the U.S. Food and Drug Administration (FDA), and the fact that some of these products are now being manufactured using nanotechnology creates an additional layer of complexity. Is FDA equipped to meet the emerging regulatory challenge of dietary supplements that use engineered nanomaterials?
  • events/archive January 14, 2009 Nanotech and Your Daily Vitamins Historically, the regulation of dietary supplements has been a significant challenge for the U.S. Food and Drug Administration (FDA), and the fact that some of these products are now being manufactured using nanotechnology creates an additional layer of complexity. Is FDA equipped to meet the emerging regulatory challenge of dietary supplements that use engineered nanomaterials? video
  • news/archive January 14, 2009 Getting Your Daily Dose of Nano? The ability of the FDA to regulate the safety of dietary supplements using nanomaterials is severely limited by lack of information, lack of resources and the agency’s lack of statutory authority in certain critical areas, according to: A Hard Pill To Swallow: Barriers to Effective FDA Regulation of Nanotechnology-Based Dietary Supplements, a new report by former FDA officials William B. Schultz and Lisa Barclay.
  • events/archive January 8, 2009 Synthetic Biology: Is Ethics a Showstopper? Synthetic biology promises to enable cheap, lifesaving new drugs to treat the 350-500 million people who suffer from malaria, and to create innovative biofuels that can help solve the world’s energy problems. But are synthetic biologists playing God? Will synthetic biology’s expected products and profits be stymied by policymakers and the public? Join us and explore these unresolved questions with Dr. Arthur Caplan, director of the Center for Bioethics at the University of Pennsylvania.